|
1
|
Lassman AB: Molecular biology of gliomas.
Curr Neurol Neurosci Rep. 4:228–233. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dolecek TA, Propp JM, Stroup NE and
Kruchko C: CBTRUS statistical report: Primary brain and central
nervous system tumors diagnosed in the United States in 2005–2009.
Neuro Oncol. 14 Suppl 5:v1–v49. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ostrom QT, Bauchet L, Davis FG, Deltour I,
Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh
KM, et al: The epidemiology of glioma in adults: A ‘state of the
science’ review. Neuro Oncol. 16:896–913. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ostrom QT, Gittleman H, Farah P, Ondracek
A, Chen Y, Wolinsky Y, Stroup NE, Kruchko C and Barnholtz-Sloan JS:
CBTRUS statistical report: Primary brain and central nervous system
tumors diagnosed in the United States in 2006–2010. Neuro Oncol. 15
Suppl 2:ii1–ii56. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee CH, Jung KW, Yoo H, Park S and Lee SH:
Epidemiology of primary brain and central nervous system tumors in
Korea. J Korean Neurosurg Soc. 48:145–152. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gigineishvili D, Shengelia N, Shalashvili
G, Rohrmann S, Tsiskaridze A and Shakarishvili R: Primary brain
tumour epidemiology in Georgia: First-year results of a
population-based study. J Neurooncol. 112:241–246. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dubrow R and Darefsky AS: Demographic
variation in incidence of adult glioma by subtype, United States,
1992–2007. BMC Cancer. 11:3252011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Watkins S and Sontheimer H: Unique biology
of gliomas: Challenges and opportunities. Trends Neurosci.
35:546–556. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sanai N and Berger MS: Recent surgical
management of gliomasGlioma. Yamanaka R: 746. Springer; New York:
pp. 12–25. 2012, View Article : Google Scholar
|
|
10
|
Roth P, Silginer M, Goodman SL, Hasenbach
K, Thies S, Maurer G, Schraml P, Tabatabai G, Moch H, Tritschler I
and Weller M: Integrin control of the transforming growth factor-β
pathway in glioblastoma. Brain. 136:564–576. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lv S, Qin J, Yi R, Coreman M, Shi R, Kang
H and Yao C: CrkL efficiently mediates cell proliferation,
migration, and invasion induced by TGF-β pathway in glioblastoma. J
Mol Neurosci. 51:1046–1051. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Feinberg AP and Tycko B: The history of
cancer epigenetics. Nat Rev Cancer. 4:143–153. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hegi ME, Diserens AC, Gorlia T, Hamou MF,
de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani
L, et al: MGMT gene silencing and benefit from temozolomide in
glioblastoma. N Engl J Med. 352:997–1003. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kunitz A, Wolter M, Van den Boom J,
Felsberg J, Tews B, Hahn M, Benner A, Sabel M, Lichter P,
Reifenberger G, et al: DNA hypermethylation and aberrant expression
of the EMP3 gene at 19q13. 3 in human gliomas. Brain Pathol.
17:363–370. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zschocke J, Allritz C, Engele J and Rein
T: DNA methylation dependent silencing of the human glutamate
transporter EAAT2 gene in glial cells. Glia. 55:663–674. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sandberg CJ, Altschuler G, Jeong J,
Strømme KK, Stangeland B, Murrell W, Grasmo-Wendler UH, Myklebost
O, Helseth E, Vik-Mo EO, et al: Comparison of glioma stem cells to
neural stem cells from the adult human brain identifies
dysregulated Wnt-signaling and a fingerprint associated with
clinical outcome. Exp Cell Res. 319:2230–2243. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: Limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Irizarry RA, Hobbs B, Collin F,
Beazer-Barclay YD, Antonellis KJ, Scherf U and Speed TP:
Exploration, normalization, and summaries of high density
oligonucleotide array probe level data. Biostatistics. 4:249–264.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Smyth G: Limma: Linear models for
microarray dataBioinformatics and computational biology solutions
using R and Bioconductor. Gentleman R, Carey V, Dudoit S, Irizarry
R and Huber W: Springer; New York: pp. 397–420. 2005, View Article : Google Scholar
|
|
20
|
Benjamini Y and Hochberg Y: Controlling
the false discovery rate: A practical and powerful approach to
multiple testing. J Royal Statistic Soci. Series B
(Methodological). 57:289–300. 1995.
|
|
21
|
Szekely GJ and Rizzo ML: Hierarchical
clustering via joint between-within distances: Extending Ward's
minimum variance method. Journal of Classification. 22:151–183.
2005. View Article : Google Scholar
|
|
22
|
Deza MM and Deza E: Encyclopedia of
distances. Springer; 2009, View Article : Google Scholar
|
|
23
|
Wang L, Cao C, Ma Q, Zeng Q, Wang H, Cheng
Z, Zhu G, Qi J, Ma H, Nian H and Wang Y: RNA-seq analyses of
multiple meristems of soybean: Novel and alternative transcripts,
evolutionary and functional implications. BMC Plant Biol.
14:1692014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Szklarczyk D, Franceschini A, Kuhn M,
Simonovic M, Roth A, Minguez P, Doerks T, Stark M, Muller J, Bork
P, et al: The STRING database in 2011: Functional interaction
networks of proteins, globally integrated and scored. Nucleic Acids
Res. 39(Database Issue): D561–D568. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Obayashi T, Kinoshita K, Nakai K, Shibaoka
M, Hayashi S, Saeki M, Shibata D, Saito K and Ohta H: ATTED-II: A
database of co-expressed genes and cis elements for identifying
co-regulated gene groups in Arabidopsis. Nucleic Acids Res.
35(Database Issue): D863–D869. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Smoot ME, Ono K, Ruscheinski J, Wang PL
and Ideker T: Cytoscape 2.8: New features for data integration and
network visualization. Bioinformatics. 27:431–432. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang DW, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: Paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology. The gene
ontology consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mao X, Cai T, Olyarchuk JG and Wei L:
Automated genome annotation and pathway identification using the
KEGG Orthology (KO) as a controlled vocabulary. Bioinformatics.
21:3787–3793. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Motakis E, Ivshina AV and Kuznetsov VA:
Data-driven approach to predict survival of cancer patients:
Estimation of microarray genes' prediction significance by Cox
proportional hazard regression model. IEEE Eng Med Biol Mag.
28:58–66. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu W, Hao XS, Fan Q, Li HX, Song LN, Wang
SJ, Wang PZ, Jin Y, Chen Y, Guan LY, et al: Cox proportional hazard
model analysis of prognosis in patients with carcinoma of esophagus
and gastric cardia after radical resection. Zhonghua Zhong Liu Za
Zhi. 30:921–925. 2008.(In Chinese). PubMed/NCBI
|
|
32
|
Zhang B, Kirov S and Snoddy J: WebGestalt:
An integrated system for exploring gene sets in various biological
contexts. Nucleic Acids Res. 33(Web Server Issue): W741–W748. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Park JH, Jeong YJ, Won HK, Choi SY, Park
JH and Oh SM: Activation of TOPK by lipopolysaccharide promotes
induction of inducible nitric oxide synthase through NF-κB activity
in leukemia cells. Cell Signal. 26:849–856. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Park JH, Lin ML, Nishidate T, Nakamura Y
and Katagiri T: PDZ-binding kinase/T-LAK cell-originated protein
kinase, a putative cancer/testis antigen with an oncogenic activity
in breast cancer. Cancer Res. 66:9186–9195. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Stangeland B, Mughal AA, Grieg Z, Sandberg
CJ, Joel M, Nygard S, Meling T, Murrell W, Vik Mo EO and Langmoen
IA: Combined expressional analysis, bioinformatics and targeted
proteomics identify new potential therapeutic targets in
glioblastoma stem cells. Oncotarget. 6:26192–26215. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wei B, Wang L, Du C, Hu G, Wang L, Jin Y
and Kong D: Identification of differentially expressed genes
regulated by transcription factors in glioblastomas by
bioinformatics analysis. Mol Med Rep. 11:2548–2554. 2015.PubMed/NCBI
|
|
37
|
Freitas M, Malheiros S, Stávale JN, Biassi
TP, Zamunér FT, de Souza Begnami M, Soares FA and Vettore AL:
Expression of cancer/testis antigens is correlated with improved
survival in glioblastoma. Oncotarget. 4:6362013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Joel M, Mughal AA, Grieg Z, Murrell W,
Palmero S, Mikkelsen B, Fjerdingstad HB, Sandberg CJ, Behnan J,
Glover JC, et al: Targeting PBK/TOPK decreases growth and survival
of glioma initiating cells in vitro and attenuates tumor growth in
vivo. Mol Cancer. 14:1212015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Escargueil AE, Plisov SY, Filhol O, Cochet
C and Larsen AK: Mitotic phosphorylation of DNA topoisomerase II
alpha by protein kinase CK2 creates the MPM-2 phosphoepitope on
Ser-1469. J Biol Chem. 275:34710–34718. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fasching PA, Weihbrecht S, Haeberle L,
Gasparyan A, Villalobos IE, Ma Y, Ekici AB, Wachter DL, Hartmann A,
Beckmann MW, et al: HER2 and TOP2A amplification in a
hospital-based cohort of breast cancer patients: Associations with
patient and tumor characteristics. Breast Cancer Res Treat.
145:193–203. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Jain M, Zhang L, He M, Zhang YQ, Nilubol
N, Shen M and Kebebew E: TOP2A is a therapeutic target for
adrenocortical carcinoma. Cancer Res. 73:35432013. View Article : Google Scholar
|
|
42
|
Kirk J, Schaarschuch K, Dalimov Z, Lasorsa
E, Ku S, Ramakrishnan S, Hu Q, Azabdaftari G, Wang J, Pili R and
Ellis L: Top2a identifies and provides epigenetic rationale for
novel combination therapeutic strategies for aggressive prostate
cancer. Oncotarget. 6:3136–3146. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tsavaris N, Lazaris A, Kosmas C, Gouveris
P, Kavantzas N, Kopterides P, Papathomas T, Arapogiannis G, Zorzos
H, Kyriakou V and Patsouris E: Topoisomerase I and IIalpha protein
expression in primary colorectal cancer and recurrences following
5-fluorouracil-based adjuvant chemotherapy. Cancer Chemother
Pharmacol. 64:391–398. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Arivazhagan A, Kumar DM, Sagar V, Patric
IR, Sridevi S, Thota B, Srividya MR, Prasanna K, Thennarasu K,
Mondal N, et al: Higher topoisomerase 2 alpha gene transcript
levels predict better prognosis in GBM patients receiving
temozolomide chemotherapy: Identification of temozolomide as a
TOP2A inhibitor. J Neurooncol. 107:289–297. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Bie L, Zhao G, Cheng P, Rondeau G,
Porwollik S, Ju Y, Xia XQ and McClelland M: The accuracy of
survival time prediction for patients with glioma is improved by
measuring mitotic spindle checkpoint gene expression. PLoS One.
6:e256312011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhang X, Yang H, Gong B, Jiang C and Yang
L: Combined gene expression and protein interaction analysis of
dynamic modularity in glioma prognosis. J Neurooncol. 107:281–288.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Schultz SJ, Fry AM, Sütterlin C, Ried T
and Nigg EA: Cell cycle-dependent expression of Nek2, a novel human
protein kinase related to the NIMA mitotic regulator of Aspergillus
nidulans. Cell Growth Differ. 5:625–635. 1994.PubMed/NCBI
|
|
48
|
Laakso M and Hautaniemi S: DEGs in
Glioblastoma. 2011, http://csbi.ltdk.helsinki.fi/camda/candidateReport-document.pdfFebruary
2–2015
|
|
49
|
Chen YJ, Lin HS and Jiang JK:
Overexpression of nek2 in colorectal carcinoma. Cancer Research.
68:55092008.
|
|
50
|
Cappello P, Blaser H, Gorrini C, Lin D,
Elia A, Wakeham A, Haider S, Boutros P, Mason J, Miller NA, et al:
Role of Nek2 on centrosome duplication and aneuploidy in breast
cancer cells. Oncogene. 33:2375–2384. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Evan GI and Vousden KH: Proliferation,
cell cycle and apoptosis in cancer. Nature. 411:342–348. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Kastan MB and Bartek J: Cell-cycle
checkpoints and cancer. Nature. 432:316–323. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Vermeulen K, Van Bockstaele DR and
Berneman ZN: The cell cycle: A review of regulation, deregulation
and therapeutic targets in cancer. Cell Prolif. 36:131–149. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Tang S, Bonaroti J, Unlu S, Liang X, Tang
D, Zeh HJ and Lotze MT: Sweating the small stuff: microRNAs and
genetic changes define pancreatic cancer. Pancreas. 42:740–759.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Gollin SM, Parikh RA and Huang X: Genetic
changes in ATM and ATR/CHEK1 as prognostic indicators in cancer US
Patent 20130338212 A1. June 10–2013, issued December 19. 2013
|
|
56
|
Cairns RA, Harris IS and Mak TW:
Regulation of cancer cell metabolism. Nat Rev Cancer. 11:85–95.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Fourest-Lieuvin A, Peris L, Gache V,
Garcia-Saez I, Juillan-Binard C, Lantez V and Job D: Microtubule
regulation in mitosis: Tubulin phosphorylation by the
cyclin-dependent kinase Cdk1. Mol Biol Cell. 17:1041–1050. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Gu Y, Rosenblatt J and Morgan DO: Cell
cycle regulation of CDK2 activity by phosphorylation of Thr160 and
Tyr15. Embo J. 11:3995–4005. 1992.PubMed/NCBI
|
|
59
|
Chen H, Huang Q, Zhai DZ, Dong J, Wang AD
and Lan Q: CDK1 expression and effects of CDK1 silencing on the
malignant phenotype of glioma cells. Zhonghua Zhong Liu Za Zhi.
29:484–488. 2007.PubMed/NCBI
|
|
60
|
Zhang R, Banik NL and Ray SK: Combination
of all-trans retinoic acid and interferon-gamma upregulated
p27(kip1) and down regulated CDK2 to cause cell cycle arrest
leading to differentiation and apoptosis in human glioblastoma LN18
(PTEN-proficient) and U87MG (PTEN-deficient) cells. Cancer
Chemother Pharmacol. 62:407–416. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Zhang J, Liu B, Jiang X, Zhao H, Fan M,
Fan Z, Lee JJ, Jiang T, Jiang T and Song SW: A systems
biology-based gene expression classifier of glioblastoma predicts
survival with solid tumors. PLoS One. 4:e62742009. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Kong DS, Song SY, Kim DH, Joo KM, Yoo JS,
Koh JS, Dong SM, Suh YL, Lee JI, Park K, et al: Prognostic
significance of c-Met expression in glioblastomas. Cancer.
115:140–148. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Kirla RM, Haapasalo HK, Kalimo H and
Salminen EK: Low expression of p27 indicates a poor prognosis in
patients with high-grade astrocytomas. Cancer. 97:644–648. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Saha P, Chen J, Thome KC, Lawlis SJ, Hou
ZH, Hendricks M, Parvin JD and Dutta A: Human CDC6/Cdc18 associates
with Orc1 and cyclin-cdk and is selectively eliminated from the
nucleus at the onset of S phase. Mol Cell Biol. 18:2758–2767. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Ohta S, Koide M, Tokuyama T, Yokota N,
Nishizawa S and Namba H: Cdc6 expression as a marker of
proliferative activity in brain tumors. Oncol Rep. 8:1063–1066.
2001.PubMed/NCBI
|
|
66
|
Petri ET, Errico A, Escobedo L, Hunt T and
Basavappa R: The crystal structure of human cyclin B. Cell Cycle.
6:1342–1349. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Zhang J, Zhao P, Fu Z, Chen X, Liu N, Lu
A, Li R, Shi L, Pu P, Kang C and You Y: Glioma cells enhance
endothelial progenitor cell angiogenesis via VEGFR-2, not VEGFR-1.
Oncol Rep. 20:1457–1463. 2008.PubMed/NCBI
|
|
68
|
Ducray F, Idbaih A, de Reyniès A, Bièche
I, Thillet J, Mokhtari K, Lair S, Marie Y, Paris S, Vidaud M, et
al: Anaplastic oligodendrogliomas with 1p19q codeletion have a
proneural gene expression profile. Mol Cancer. 7:412008. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Bode AM and Dong Z: Post-translational
modification of p53 in tumorigenesis. Nat Rev Cancer. 4:793–805.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Tanaka H, Arakawa H, Yamaguchi T,
Shiraishi K, Fukuda S, Matsui K, Takei Y and Nakamura Y: A
ribonucleotide reductase gene involved in a p53-dependent
cell-cycle checkpoint for DNA damage. Nature. 404:42–49. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Mao H, LeBrun DG, Yang J, Zhu VF and Li M:
Deregulated signaling pathways in glioblastoma multiforme:
Molecular mechanisms and therapeutic targets. Cancer Invest.
30:48–56. 2012. View Article : Google Scholar : PubMed/NCBI
|
